期刊文献+

脑胶质瘤VEGF表达与动态增强MRI灌注成像的相关性研究 被引量:3

Correlation between dynamic contrast-enhanced MR imaging and the expression of VEGF in cerebral gliomas
下载PDF
导出
摘要 目的:探讨脑胶质瘤血管内皮生长因子(VEGF)表达与动态增强MRI灌注成像之间的相关性。材料与方法:对37例证实为脑胶质瘤的患者术前行动态增强MRI灌注成像,获得反映局部血流灌注的3个参数,rrCBV、rrCBF、TTP*,对术后的病理切片采用免疫组化法测定组织内VEGF的表达。分析VEGF与胶质瘤组织学级别的关系,并对血流动力学参数与VEGF表达间进行相关性检验。结果:VEGF在不同级别胶质瘤组中的表达具有显著性差异,VEGF与rrCBV、rrCBF具有明显的正相关,r分别为0.699和0.558。结论:VEGF作为促进胶质瘤血管生成最重要的调节因子,其表达程度的高低与分级密切相关,动态增强MRI灌注成像可以作为预测VEGF表达的一种新方法,从而为抗血管治疗提供依据。 Objective: To study the correlations between the expressions of VEGF in cerebral gliomas with its pathologic grade and dynamic contrast-enhanced MR imaging. Methods: Dynamic contrast-enhanced MR imaging was performed in 37 glioma patients preoperatively. The perfusion data were processed to obtain three parameters reflecting the microcirculation: Max rrCBV, rrCBF and TrP*. The expressions of VEGF were measured using immuno-bistocbemical technique. The correla- tions between the expression of VEGF, pathologic grade of tumor and dynamic MRI parameters were studied. Results: Differences of the VEGF expressions among three grade groups of tumor were statistically significant. The expression of VEGF was significantly positive correlated with the Max rrCBV, rrCBF(r-=0.699, P=0.001; r=0.558, P=0.011) respectively. Negative correlation were found between VEGF and TTP*, no statistical significance can be observed. Conclusion: As the most important regulation factor, VEGF has close relation with pathologic grade. Dynamic contrast-enhanced MR imaging can be used to assess the expression of VEGF, the technique has a good prospect in clinical antivascular therapy.
出处 《中国临床医学影像杂志》 CAS 北大核心 2005年第10期547-549,580,共4页 Journal of China Clinic Medical Imaging
基金 甘肃省教委2003-2004年立项课题(编号033B-11)
关键词 血管内皮生长因子类 脑肿瘤 神经胶质瘤 磁共振成像 vascular endothelial growth factors brain neoplasms glioma magnetic resonance imaging
  • 相关文献

参考文献10

  • 1Shimizu M, Saitoh Y, Itoh H. Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues[J]. Hum Pathol, 1990, 21:607-612.
  • 2Deroanne CF, Hajiton A, Calberg CM, et al. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrin upregulation of vascular endothelial growth factor expression[J]. Cancer Res, 1997, 57(24) :5590-5597.
  • 3Plate KH, Breier G, Weich HA, et al. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo[J]. Nature, 1992, 359(6398):845-848.
  • 4Samtomo K, Ikezaki K, Ono M, et al. Expression of vascular growth factor and its possible relation with neovascularization in human brain tumors[J]. Cancer Res, 1995, 55(5): 1189-1193.
  • 5Takekawa Y, Sawada T. Vascular endothelial growth factor and neovascularization in astrocytic tumors[J]. Pathol Int, 1998, 48(2): 109-114.
  • 6叶社房,钟雪云,陈运贤.脑星形细胞瘤中p53和VEGF的表达及其与肿瘤血管形成的关系[J].中华肿瘤杂志,2001,23(4):326-329. 被引量:19
  • 7Abdulrauf SI, Edvardsen K, Ho KL, et al. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma [J]. J Neurosurg, 1998, 88(3):513-520.
  • 8Kim K J, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo[J]. Nature, 1993, 362(6423):841-844.
  • 9Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging [J]. Radiology,1999, 211(3):791-798.
  • 10Sugahara T, Korogi Y, Shigematsu Y, et al. Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors[J]. Top Magn Reson Imaging, 1999,10(2): 114-124.

二级参考文献1

  • 1Weidner N,New Engl J Med,1991年,324卷,1页

共引文献18

同被引文献33

  • 1钟华,彭振鹏,刘锦文,程传虎.宫颈癌MRI动态增强的病理学研究:附20例报告[J].南方医科大学学报,2009,29(7):1491-1492. 被引量:6
  • 2Provenzale JM, Mukundan S, Barboriak DP. Diffusion- weighted and perfusion MR imaging for brain tumor character- ization and assessment of treatment response [ J ]. Radiology, 2006, 239(3) :632-649.
  • 3Sung HB, Gong YJ, Young MH, et al. Usefulness of tissue permeability factor in differentiating benign and malignant pul- monary lesions on dynamic contrast-enhanced MRI [ J ]. Ko- rean Soc Radiol, 2013, 69(1):57-65.
  • 4Yaron G, Sasan P, Matthias ME, et al. Dynamic contrast- enhanced magnetic resonance imaging: fundamentals and ap- plication to the evaluation of the peripheral perfusion [ J ]. Cardiovasc Diagn Ther, 2014, 4(2) :147-164.
  • 5Shin KE, Ahn KJ, Choi HC, et al. DCE and DSC MR per- fusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma [ J ]. Clin Radiol, 2014, 69(6):e264-e272.
  • 6Turkbey B, Thomasson D, Pang Y, et al. The role of dy- namic contrast-enhanced MRI in cancer diagnosis and treat- ment [J]. Diagn Interv Radiol, 2010, 16(3) :186-192.
  • 7Law M, Young R, Babb J, et al. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas [J]. AJNR Am J Neuroradiol, 2007, 28(4) :761-766.
  • 8Yao WW, Zhang H, Ding B, et al. Rectal cancer: 3D dy- namic contrast-enhanced MRI correlation with microvascular density and clinicopathological features [ J ]. Radiol Med, 2011, 116(3) :366-374.
  • 9Choi HS, Kim AH, Ahn SS, et al. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI [J]. Korean J Radiol, 2013, 14 (3) :487-492.
  • 10Jia ZZ, Geng DY, Xie TW, et al. Quantitative analysis of neovascular permeability in glioma by dynamic contrast-en- hanced MR imaging [ J ]. Clin Neurosci, 2012, 19 (6) : 820-823.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部